What are the mechanisms by which microglial senescence contributes to Alzheimer disease and Parkinson disease progression, and what therapeutic strategies could target senescent microglia?
Landscape Summary: Microglial senescence in Alzheimer and Parkinson disease progression is a 0.85 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.
Colonna, Sevlever, et al. (TREM2 biology)
Microglial senescence in Alzheimer and Parkinson disease progression — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: